Christoph Nabzdyk Selected Research

Christoph Nabzdyk Research Topics

2	Pneumonia (Pneumonitis) 04/2021 - 05/2009
2	Inflammation (Inflammations) 01/2016 - 01/2009
2	Wounds and Injuries (Trauma) 09/2013 - 05/2009
1	Shock 01/2022
1	Vasoplegia 01/2022
1	Pneumothorax 04/2021
1	COVID-19 04/2021
1	Barotrauma 04/2021
1	Lung Injury 04/2021
1	Mediastinal Emphysema (Pneumomediastinum) 04/2021
1	Thrombosis (Thrombus) 10/2020
1	Propofol Infusion Syndrome 08/2020
1	Edema (Dropsy) 01/2016
1	Ischemia 09/2013
1	Infarction (Infarctions) 09/2010
1	Infections 05/2009
1	Type 2 Diabetes Mellitus (MODY) 01/2009
1	Myocardial Infarction 02/2007
1	Heart Failure 02/2007

2	NeuropeptidesIBA 09/2013 - 01/2009
1	Hydroxocobalamin FDA Link 01/2022
1	Oxygen (Dioxygen)IBA 04/2021
1	HydrogelsIBA 10/2020
1	Hematoxylin (Haematoxylon)IBA 01/2016
1	Perilipin-1IBA 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 09/2013
1	CytokinesIBA 09/2013
1	SolutionsIBA 09/2010

1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022
1	Artificial Respiration (Mechanical Ventilation) 04/2021
1	Cannula 04/2021
1	Noninvasive Ventilation 04/2021
1	Extracorporeal Membrane Oxygenation 08/2020
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 05/2009
1	Heart-Assist Devices 05/2009
1	Surgical Amputation (Amputations) 01/2009
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2007